SEATTLE, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced upcoming presentations at ASN Kidney Week 2021 from November 4-7, 2021. The six abstracts covering the BION-1301 and atrasentan clinical programs will be delivered as ePoster presentations.
- For more information on these and other abstracts, please visit the ASN Kidney Week 2021 website and Abstract Supplement .
- To access the live webcast and subsequent archived recording of this and other company presentations, please visit the Investors section of Chinooks website.
- Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases.
- Chinooks product candidates are being investigated in rare, severe chronic kidney disorders with opportunities for well-defined clinical pathways.